Because our previous work suggested that in order to be fully effective FOXM1 inhibition must be combined with inhibition of other players in the FOXM1 myeloma network [1, 3], we searched for lead compounds that may synergize with NB73 in myeloma. This evidence concerns the gene FOXM1 and plasma cell myeloma.